advertisement
Nakakura S 23
Showing records 1 to 23 | Display all abstracts from Nakakura S81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Matsuura M
Translational vision science & technology 2019; 8: 48
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sakamoto E
Scientific reports 2019; 9: 3755
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Nishimura K; Tabuchi H
Translational vision science & technology 2019; 8: 55
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Ishida W
Scientific reports 2019; 9: 3755
81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Murata H; Fujino Y
Translational vision science & technology 2019; 8: 48
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Nakakura S
Translational vision science & technology 2019; 8: 55
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sumi T
Scientific reports 2019; 9: 3755
81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Yanagisawa M
Translational vision science & technology 2019; 8: 48
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kishimoto T
Scientific reports 2019; 9: 3755
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Nakatani Y
Translational vision science & technology 2019; 8: 55
81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Nakao Y
Translational vision science & technology 2019; 8: 48
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Tada K
Scientific reports 2019; 9: 3755
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Yorihiro A; Hasegawa S
Translational vision science & technology 2019; 8: 55
81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Nakakura S
Translational vision science & technology 2019; 8: 48
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Fukuda K; Yoneda T
Scientific reports 2019; 9: 3755
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Tanabe H
Translational vision science & technology 2019; 8: 55
81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Kiuchi Y
Translational vision science & technology 2019; 8: 48
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Noguchi A
Translational vision science & technology 2019; 8: 55
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kuroiwa H
Scientific reports 2019; 9: 3755
81407 Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST
Asaoka R
Translational vision science & technology 2019; 8: 48
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Terao E
Scientific reports 2019; 9: 3755
81417 Evaluation of Automatic Monitoring of Instillation Adherence Using Eye Dropper Bottle Sensor and Deep Learning in Patients With Glaucoma
Aoki R; Kiuchi Y
Translational vision science & technology 2019; 8: 55
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Fujisawa Y; Nakakura S; Jian K; Okumichi H; Kiuchi Y; Fukushima A
Scientific reports 2019; 9: 3755
